tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Zemansky, 9 are a BUY (50%), 8 are a HOLD (44.44%), 1 are a SELL (5.56%).
Analyst Jason Zemansky works at BAML with a stock forecast success ratio of 33.33% fulfilled within 49.5 days on average.
Jason Zemansky’s has documented 34 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ESPR, Esperion Therapeutics at 03-Jan-2024.
Analyst best performing recommendations are on ESPR (ESPERION THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 3/16/2023. The price target of $1.5 was fulfilled within 6 days with a profit of $0.32 (17.58%) receiving and performance score of 29.3.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1
$-0.13 (-11.50%)
1.5
3 months 2 days ago
5/6 (83.33%)
$-0.02 (-1.96%)
301
Buy
3
$1.87 (165.49%)
3 months 2 days ago
0/2 (0%)
$1.98 (194.12%)
Buy
4 months 1 days ago
1/1 (100%)
$32.69 (83.16%)
358
Buy
9
$7.87 (696.46%)
11 months 8 days ago
2/4 (50%)
$4.84 (116.35%)
178
Buy
7
$5.87 (519.47%)
7
1 years 1 months 12 days ago
1/3 (33.33%)
$0.45 (6.87%)
57
Which stock is Jason Zemansky is most bullish on?
What Year was the first public recommendation made by Jason Zemansky?
